SCHEMBL23258014

SCHEMBL23258014

CC[C@H](O)c1cc2ccc(F)cc2o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.42
HIF1A Q16665 1/20 0.42
APP P05067 1/20 0.38
PGR P06401 1/20 0.35
CYP19A1 P11511 4/20 0.35
TRPA1 O75762 1/20 0.35
GAA P10253 2/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
MGAM O43451 1/20 0.35
SI P14410 1/20 0.35
PTPN1 P18031 1/20 0.35
ACHE P22303 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
PDE2A O00408 1/20 0.34
KMT2A Q03164 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24174705 0.87 CYP2D6 (0.39) CYP2D6HIF1AAPPTRPA1PDE2A
SCHEMBL23257824 0.80 CA12 (0.45) CYP2D6HIF1AAPPPGRCYP19A1
SCHEMBL23258648 0.78 CYP2D6 (0.40) CYP2D6HIF1AAPPTRPA1GAA
SCHEMBL29172969 0.77 CYP2D6 (0.60) CYP2D6HIF1ARAB9ANPC1KMT2A
SCHEMBL24173635 0.77 CYP2D6 (0.60) CYP2D6HIF1ARAB9ANPC1KMT2A
SCHEMBL9262623 0.74 MEN1 (0.46) CYP2D6HIF1ACYP19A1KMT2AMEN1
SCHEMBL24176956 0.74 CYP11B2 (0.40) CYP2D6HIF1APDE2AKMT2AKDM4E
SCHEMBL20559553 0.74 GAA (0.41) CYP2D6HIF1AAPPPGRCYP19A1
SCHEMBL9826932 0.74 GAA (0.41) CYP2D6HIF1AAPPPGRCYP19A1
SCHEMBL12967200 0.72 APP (0.41) APPPGRCYP19A1GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021074197-A1 THIENOPYRIMIDONES AS TRPA1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-04-22 WO disclosed